Abstract:Lymphatic vessels play a crucial role in draining excess fluid and transport macromolecular substances from extracellular spaces. Disfunction of lymphatic vessels may cause lymph edema and chronic inflammation, leading to fibrosis of the local tissue. This study investigated efficiency of transplantation of lymphatic endothelial progenitor cell (LEPCs) and sustained release of VEGF-C from self-assembling peptide (SAP) on promoting lymphangiogenesis after myocardial infarction (MI). CD34+VEGFR-3+ EPCs were isolated from rat bone marrow. Sustained release of VEGF-C from SAP nanofibers (SAPNs) was detected with ELISA. Compatibility of SAPNs with the cells was accessed with transmission electron microscopy and EB/ AO staining. After rat MI models were established with ligation of the anterior descending branch of the left coronary artery, SAP carrying the cells and VEGF-C was injected at the border of the infarcted region. At four week after transplantation, the survival and differentiation of the cells labeled with GFP were examined, and repair of the infarcted myocardium was evaluated. Under induction with VEGF-C, CD34+VEGFR-3+ EPCs could differentiate into lymphatic endothelial cells. The cells spread well along SAPNs. SAPNs protected the cells from apoptosis in the condition of hypoxia, and released VEGF-C sustainedly. After transplantation, cardiac function was improved significantly. The number of the survived cells increased, and some cells differentiated into lymphatic endothelial cells. Density of lymphatic vessels increased, and cardiac edema was reduced. Moreover, angiogenesis and myocardial regeneration were enhanced. These results suggest that SAPNs load LEPCs and release VEGF-C effectively. VEGF-C released from SAPNs induces differentiation of LEPCs towards lymphatic endothelial cells. Loading stem cells and releasing growth factor with SAPNs is a promised strategy for MI therapy. References: 1. Wang Q L, Wang H J, Li Z H, Wang Y L, Wu X P and Tan Y Z (2017) Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium. J Cell Mol Med. 21:1751–66. 2. Zhou P, Tan Y Z, Wang H J and Wang G D (2017) Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb. J Cell Mol Med. 21:2452–64. 3. Wang G D, Tan Y Z, Wang H J and Zhou P (2017) Autophagy promotes degradation of polyethyleneimine– alginate nanoparticles in endothelial progenitor cells. Note: This work was presented in Joint Event on 22nd Edition of International Conference on Immunology and Evolution of Infectious Diseases & 12th Edition of International Conference on Tissue Engineering and Regenerative Medicine during May 10-11, 2018 Frankfurt, Germany

Sustained Delivery of VEGF from Designer Self-Assembling Peptides Improves Cardiac Function after Myocardial Infarction

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.

Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction.

Intramyocardial delivery of VEGF 165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction

Designer Functionalized Self-Assembling Peptide Nanofiber Scaffolds for Growth, Migration, and Tubulogenesis of Human Umbilical Vein Endothelial Cells

Delivery of Stem Cells and BMP-2 With Functionalized Self-Assembling Peptide Enhances Regeneration of Infarcted Myocardium

Peptides-tethered Vascular Grafts Enable Blood Vessel Regeneration Via Endogenous Cell Recruitment and Neovascularization

Artificial apoptotic cells/VEGF-loaded injectable hydrogel united with immunomodification and revascularization functions to reduce cardiac remodeling after myocardial infarction

In Vivo Studies on Angiogenic Activity of Two Designer Self-Assembling Peptide Scaffold Hydrogels in the Chicken Embryo Chorioallantoic Membrane

Transplantation Of Novel Vascular Endothelial Growth Factor Gene Delivery System Manipulated Skeletal Myoblasts Promote Myocardial Repair

Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization

Injectable Citrate-Based Hydrogel As an Angiogenic Biomaterial Improves Cardiac Repair after Myocardial Infarction.

Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI

Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium.

Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium.

Transplantation of Nanoparticle Transfected Skeletal Myoblasts Overexpressing Vascular Endothelial Growth Factor-165 for Cardiac Repair

Lymphatic Endothelial Progenitor Cells and VEGF-C Loaded with Self-Assembling Peptide Nanofibers Promote Lymphangiogenesis in Infarcted Myocardium

Intramyocardial Injection of Vascular Endothelial Growth Factor Gene Improves Cardiac Performance and Inhibits Cardiomyocyte Apoptosis.

Peptide Functionalized Biomimetic Gene Complexes Enhance Specificity for Vascular Endothelial Regeneration

PRESERVATION OF THE CARDIAC FUNCTION IN INFARCTED RAT HEARTS BY THE TRANSPLANTATION OF ADIPOSE-DERIVED STEM CELLS WITH INJECTABLE FIBRIN SCAFFOLDS

Gene Delivery of Hypoxia-Inducible VEGF Targeting Collagen Effectively Improves Cardiac Function after Myocardial Infarction.